The organ preservation market comprises of small and big players such as Organ Recovery Systems, Inc. (U.S.), Xvivo Perfusion AB (Sweden), Essential Pharmaceuticals, LLC (U.S.), Transmedics, Inc. (U.S.), Paragonix Technologies, Inc. (U.S), 21^st Century Medicine, Inc.(U.S.), Dr. Franz Kohler Chemie GmbH (Germany), Preservation Solutions, Inc. (U.S.), OrganOx Limited (U.K), and Bridge to Life, Ltd. (U.S.)and Waters Medical Systems, LLC (U.S.)

Client acquisitions, approvals & certifications, market expansions, and other (product launches and integrations, agreements, and contracts) are the major developments undertaken by the players to achieve growth in this market. Client acquisitions accounted for ~41% of the total developments undertaken by the players in this market. Some of the significant client acquisitions have been experienced by Lifeline Scientific, Inc. (U.S.) and Transmedics, Inc., (U.S.) OrganOx, Ltd. (U.K), Organ Assist (Netherlands) and Hibernicor LLC (U.S.).

Read More Details, Here | Download the PDF Brochure@ http://bit.ly/2Gavsdf

Approvals & Certifications accounted for ~38% of the total key developments in the market from January 2013 to May 2016. Paragonix Technolgies, Inc. (U.S.), Lifeline Scientific, Inc. (U.S.), OrganOx, Ltd. (U.K), Organ Assist (Netherlands) and Dr. Franz Kohler Chemie GmbH (Germany) were the key players that carried out these developments. One of the significant approvals was witnessed by Lifeline Scientific, Inc. from China’s Food and Drug Administration (CFDA) approving LifePort Kidney Transporter.

Market expansions accounted for ~9% of the total key developments in the organ preservation market between January 2013 and May 2016. Hemarina SA (France), Lifeline Scientific, Inc. (U.S.), and Dr. Franz Kohler Chemie GmbH (Germany) were the key players that carried out these developments. Players adopted this strategy to strengthen their networks, increase their global presence, enhance customer experience, and improve relationships with customers.

Other developments such as product launches and integrations, agreements, and contracts, accounted for ~12% of the total key developments in the organ preservation market between January 2013 and May 2016.

XVIVO Perfusion AB (Sweden), Paragonix Technologies, Inc. (U.S.), and Hemarina SA (France) were the key players that carried out these developments.

                     You Can Also Contact Our Research Experts for the Further Assistance

Scope of the Report:

This research report categorizes the market into the following segments:

Organ preservation market, by Preservation Solution:

• University of Wisconsin (UW)
• Custodiol HTK
• Perfadex
• Others (Celsior & Euro-Collins)

Organ preservation market, by Technique:

• Static Cold Storage
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion

Organ preservation market, by Organ Type:

• Kidneys
• Liver
• Lung
• Heart
• Others (Intestine & Pancreas)

Organ preservation market, by Region:

• North America
  • U.S.
  • Canada
• Europe
  • E-4( U.K, Spain, Italy & Germany)
  • Rest of Europe
• Asia-Pacific
  • China
  • Rest of Asia-Pacific
• Rest of the World (RoW)